N-[(4-chloro-2-fluorophenyl)methyl]-5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-amine;5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]-N-[(2,3,6-trifluorophenyl)methyl]pyrazin-2-amine

C40H27ClF10N10O2 — CID 159009226

IUPACN-[(4-chloro-2-fluorophenyl)methyl]-5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-amine;5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]-N-[(2,3,6-trifluorophenyl)methyl]pyrazin-2-amine
SMILESCOc1ccc2c(c1)nc(C(F)(F)F)n2-c1cnc(NCc2c(F)ccc(F)c2F)cn1.COc1ccc2c(c1)nc(C(F)(F)F)n2-c1cnc(NCc2ccc(Cl)cc2F)cn1
InChIInChI=1S/C20H14ClF4N5O.C20H13F6N5O/c1-31-13-4-5-16-15(7-13)29-19(20(23,24)25)30(16)18-10-27-17(9-28-18)26-8-11-2-3-12(21)6-14(11)22;1-32-10-2-5-15-14(6-10)30-19(20(24,25)26)31(15)17-9-28-16(8-29-17)27-7-11-12(21)3-4-13(22)18(11)23/h2-7,9-10H,8H2,1H3,(H,26,27);2-6,8-9H,7H2,1H3,(H,27,28)
InChIKeyJSHMHLOJRLIMQA-UHFFFAOYSA-N
MW905.16 g/mol
LogP10.12
Rot. Bonds10

About N-[(4-chloro-2-fluorophenyl)methyl]-5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-amine;5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]-N-[(2,3,6-trifluorophenyl)methyl]pyrazin-2-amine

N-[(4-chloro-2-fluorophenyl)methyl]-5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-amine;5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]-N-[(2,3,6-trifluorophenyl)methyl]pyrazin-2-amine (PubChem CID 159009226) has the molecular formula C40H27ClF10N10O2 and a molecular weight of 905.16 g/mol. Its IUPAC name is N-[(4-chloro-2-fluorophenyl)methyl]-5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-amine;5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]-N-[(2,3,6-trifluorophenyl)methyl]pyrazin-2-amine.

Molecular Properties

Compound NameN-[(4-chloro-2-fluorophenyl)methyl]-5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-amine;5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]-N-[(2,3,6-trifluorophenyl)methyl]pyrazin-2-amine
PubChem CID159009226
Molecular FormulaC40H27ClF10N10O2
Molecular Weight905.16 g/mol
Exact Mass904.18
IUPAC NameN-[(4-chloro-2-fluorophenyl)methyl]-5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-amine;5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]-N-[(2,3,6-trifluorophenyl)methyl]pyrazin-2-amine
SMILESCOc1ccc2c(c1)nc(C(F)(F)F)n2-c1cnc(NCc2c(F)ccc(F)c2F)cn1.COc1ccc2c(c1)nc(C(F)(F)F)n2-c1cnc(NCc2ccc(Cl)cc2F)cn1
InChIInChI=1S/C20H14ClF4N5O.C20H13F6N5O/c1-31-13-4-5-16-15(7-13)29-19(20(23,24)25)30(16)18-10-27-17(9-28-18)26-8-11-2-3-12(21)6-14(11)22;1-32-10-2-5-15-14(6-10)30-19(20(24,25)26)31(15)17-9-28-16(8-29-17)27-7-11-12(21)3-4-13(22)18(11)23/h2-7,9-10H,8H2,1H3,(H,26,27);2-6,8-9H,7H2,1H3,(H,27,28)
InChIKeyJSHMHLOJRLIMQA-UHFFFAOYSA-N
XLogP10.12
TPSA129.72 Ų
H-Bond Donors2
H-Bond Acceptors12
Rotatable Bonds10
Heavy Atoms63
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500905.16
LogP ≤ 510.12
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'halogenated_ring_1', 'substructure': 'N/A'}

Analyze N-[(4-chloro-2-fluorophenyl)methyl]-5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-amine;5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]-N-[(2,3,6-trifluorophenyl)methyl]pyrazin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[(4-chloro-2-fluorophenyl)methyl]-5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-amine;5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]-N-[(2,3,6-trifluorophenyl)methyl]pyrazin-2-amine?
The IUPAC name of N-[(4-chloro-2-fluorophenyl)methyl]-5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-amine;5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]-N-[(2,3,6-trifluorophenyl)methyl]pyrazin-2-amine (CID 159009226) is N-[(4-chloro-2-fluorophenyl)methyl]-5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-amine;5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]-N-[(2,3,6-trifluorophenyl)methyl]pyrazin-2-amine.
What is the SMILES notation for N-[(4-chloro-2-fluorophenyl)methyl]-5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-amine;5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]-N-[(2,3,6-trifluorophenyl)methyl]pyrazin-2-amine?
The canonical SMILES for N-[(4-chloro-2-fluorophenyl)methyl]-5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-amine;5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]-N-[(2,3,6-trifluorophenyl)methyl]pyrazin-2-amine is COc1ccc2c(c1)nc(C(F)(F)F)n2-c1cnc(NCc2c(F)ccc(F)c2F)cn1.COc1ccc2c(c1)nc(C(F)(F)F)n2-c1cnc(NCc2ccc(Cl)cc2F)cn1.
What is the InChIKey of N-[(4-chloro-2-fluorophenyl)methyl]-5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-amine;5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]-N-[(2,3,6-trifluorophenyl)methyl]pyrazin-2-amine?
The InChIKey is JSHMHLOJRLIMQA-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H14ClF4N5O.C20H13F6N5O/c1-31-13-4-5-16-15(7-13)29-19(20(23,24)25)30(16)18-10-27-17(9-28-18)26-8-11-2-3-12(21)6-14(11)22;1-32-10-2-5-15-14(6-10)30-19(20(24,25)26)31(15)17-9-28-16(8-29-17)27-7-11-12(21)3-4-13(22)18(11)23/h2-7,9-10H,8H2,1H3,(H,26,27);2-6,8-9H,7H2,1H3,(H,27,28).
What are the key properties of N-[(4-chloro-2-fluorophenyl)methyl]-5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-amine;5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]-N-[(2,3,6-trifluorophenyl)methyl]pyrazin-2-amine?
N-[(4-chloro-2-fluorophenyl)methyl]-5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-amine;5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]-N-[(2,3,6-trifluorophenyl)methyl]pyrazin-2-amine has a molecular weight of 905.16 g/mol, XLogP of 10.12, 10 rotatable bonds, 2 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(4-chloro-2-fluorophenyl)methyl]-5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-amine;5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]-N-[(2,3,6-trifluorophenyl)methyl]pyrazin-2-amine is sourced from PubChem (CID 159009226), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).